1. Market Research
  2. > PregLem SA - Product Pipeline Review - 2013

PregLem SA - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 23 pages

PregLem SA - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “PregLem SA - Product Pipeline Review - 2013” provides data on the PregLem SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, PregLem SA’s corporate website, SEC filings, investor presentations and featured press releases, both from PregLem SA and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- PregLem SA - Brief PregLem SA overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of PregLem SA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of PregLem SA with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the PregLem SA’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate PregLem SA’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of PregLem SA in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the PregLem SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with PregLem SA.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of PregLem SA and identify potential opportunities in those areas.

Table Of Contents

PregLem SA - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
PregLem SA Snapshot 4
PregLem SA Overview 4
Key Information 4
Key Facts 4
PregLem SA - Research and Development Overview 5
Key Therapeutic Areas 5
PregLem SA - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
PregLem SA - Pipeline Products Glance 9
PregLem SA Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
PregLem SA - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
PregLem SA - Drug Profiles 11
bentamapimod 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
PGL-1001 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
PGL-2001 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
PGL-3001 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
PregLem SA - Pipeline Analysis 15
PregLem SA - Pipeline Products by Therapeutic Class 15
PregLem SA - Pipeline Products By Target 16
PregLem SA - Pipeline Products by Route of Administration 17
PregLem SA - Pipeline Products By Mechanism of Action 18
PregLem SA - Recent Pipeline Updates 19
PregLem SA - Dormant Projects 20
PregLem SA - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables

PregLem SA, Key Information 4
PregLem SA, Key Facts 4
PregLem SA - Pipeline by Indication, 2013 6
PregLem SA - Pipeline by Stage of Development, 2013 7
PregLem SA - Monotherapy Products in Pipeline, 2013 8
PregLem SA - Phase II, 2013 9
PregLem SA - Preclinical, 2013 10
PregLem SA - Pipeline By Therapeutic Class, 2013 15
PregLem SA - Pipeline By Target, 2013 16
PregLem SA - Pipeline By Route of Administration, 2013 17
PregLem SA - Pipeline Products By Mechanism of Action, 2013 18
PregLem SA - Recent Pipeline Updates, 2013 19
PregLem SA - Dormant Developmental Projects,2013 20

List of Figures

PregLem SA - Pipeline by Indication, 2013 6
PregLem SA - Pipeline by Stage of Development, 2013 7
PregLem SA - Monotherapy Products in Pipeline, 2013 8
PregLem SA - Pipeline By Therapeutic Class, 2013 15
PregLem SA - Pipeline Products By Mechanism of Action, 2013 18

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.